venlafaxin ratiopharm 37.5 mg depotkapseli, kova
teva b.v. - venlafaxine hydrochloride - depotkapseli, kova - 37.5 mg - venlafaksiini
venlafaxin ratiopharm 75 mg depotkapseli, kova
teva b.v. - venlafaxine hydrochloride - depotkapseli, kova - 75 mg - venlafaksiini
venlafaxin ratiopharm 150 mg depotkapseli, kova
teva b.v. - venlafaxine hydrochloride - depotkapseli, kova - 150 mg - venlafaksiini
venlafaxin teva 150 mg depotkapseli, kova
teva b.v. - venlafaxine hydrochloride - depotkapseli, kova - 150 mg - venlafaksiini
venlafaxin teva 75 mg depotkapseli, kova
teva b.v. - venlafaxine hydrochloride - depotkapseli, kova - 75 mg - venlafaksiini
venlafaxin teva 37.5 mg depotkapseli, kova
teva b.v. - venlafaxine hydrochloride - depotkapseli, kova - 37.5 mg - venlafaksiini
lamzede
chiesi farmaceutici s.p.a. - velmanase alfa - alfa-mannosidosis - muut ruuansulatuselimistön sairauksien ja aineenvaihduntasairauksien lääkkeet, - hoito ei-neurologisia oireita potilailla, joilla on lievä tai kohtalainen alfa-mannosidosis.
bemfola
gedeon richter plc. - follitropiini alfa - anovulation - sukupuolihormonit ja genitaalijärjestelmään vaikuttavat aineet, - in adult women:anovulation (including polycystic ovarian disease, pcod) in women who have been unresponsive to treatment with clomiphene citrate;stimulation of multifollicular development in patients undergoing superovulation for assisted reproductive technologies (art) such as in vitro fertilisation (ivf), gamete intra-fallopian transfer (gift) and zygote intra-fallopian transfer (zift);follitropin alfa in association with a luteinising hormone (lh) preparation is recommended for the stimulation of follicular development in women with severe lh and fsh deficiency. kliinisissä tutkimuksissa näiden potilaiden käytettiin endogeenista seerumin lh-tasoa < 1. 2 iu / l. in adult men:follitropin alfa is indicated for the stimulation of spermatogenesis in men who have congenital or acquired hypogonadotrophic hypogonadism with concomitant human chorionic gonadotrophin (hcg) therapy.
pulmozyme 1 mg/ml sumutinliuos
roche oy - dornase alfa - sumutinliuos - 1 mg/ml - dornaasi alfa (desoksyribonukleaasi)
nexviadyme
sanofi b.v. - avalglucosidase alfa - glykogeenin varastointitaudin tyyppi ii - muut ruuansulatuselimistön sairauksien ja aineenvaihduntasairauksien lääkkeet, - nexviadyme (avalglucosidase alfa) is indicated for long-term enzyme replacement therapy for the treatment of patients with pompe disease (acid α-glucosidase deficiency).